Evidence map›Paper›PMID 32471707›Full record

ReviewL'Encephale2020

[Suicidal behavior in light of COVID-19 outbreak: Clinical challenges and treatment perspectives].

I Conejero, S Berrouiguet, D Ducasse, M Leboyer, V Jardon, E Olié, P Courtet

Open access · bronzeAbstract readReview
In one paragraph

Review in L'Encephale, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
3.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Anxiety, Depression and Burnout Levels of Turkish Healthcare Workers at the End of the First Period of COVID-19 Pandemic in Turkey.Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology · 2022
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

I ConejeroInserm, PSNREC, université Montpellier, CHU de Montpellier, Montpellier, France; Department of Emergency Psychiatry and Acute Care, Lapeyronie Hospital, CHU de Montpellier, Montpellier, France; FondaMental Foundation, Créteil, France.
S BerrouiguetCHU de Brest, université de Bretagne Occidentale, Brest, France.
D DucasseInserm, PSNREC, université Montpellier, CHU de Montpellier, Montpellier, France; Department of Emergency Psychiatry and Acute Care, Lapeyronie Hospital, CHU de Montpellier, Montpellier, France; FondaMental Foundation, Créteil, France.
M LeboyerInserm, fondation FondaMental, université Paris Est Créteil, AP-HP, Paris, France.
V JardonPôle de psychiatrie, médecine légale et médecine en milieu pénitentiaire, CHU de Lille, Lille, France.
E OliéInserm, PSNREC, université Montpellier, CHU de Montpellier, Montpellier, France; Department of Emergency Psychiatry and Acute Care, Lapeyronie Hospital, CHU de Montpellier, Montpellier, France; FondaMental Foundation, Créteil, France.
P CourtetInserm, PSNREC, université Montpellier, CHU de Montpellier, Montpellier, France; Department of Emergency Psychiatry and Acute Care, Lapeyronie Hospital, CHU de Montpellier, Montpellier, France; FondaMental Foundation, Créteil, France. Electronic address: philippe.courtet@univ-montp1.fr.
Inserm · FRCentre Hospitalier Universitaire de Lille · FRHôpital Lapeyronie · FRUniversité de Bretagne Occidentale · FRUniversité de Montpellier · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe COVID-19 pandemic affected today more than 3,000,000 worldwide, and more than half of humanity has been placed in quarantine. The scientific community and the political authorities fear an epidemic of suicide secondary to this crisis. The aim of this review is to analyze the impact of the COVID-19 pandemic on the dimensions of the suicidal process and its interaction with the various risk factors. We also propose innovative strategies to manage suicidal behavior in the context of pandemic.

methodsWe carried out a narrative review of international publications dealing with major pandemics (COVID-19, SARS) and their influence on suicidal vulnerability.

resultsMany factors are likely to increase the emergence of suicidal ideation and suicide attempts during this crisis. Social distancing and quarantine could increase the feeling of disconnection and the perception of social pain in vulnerable individuals. Some populations at high suicidal risk could be further impacted by the current pandemic: the elderly, medical staff and individuals exposed to economic insecurity. Several innovative tools adapted to the constraints of social distancing and quarantine may prevent suicide risk: e-health, VigilanS, buddhist-derived practices and art engagement.

conclusionsThis unprecedented crisis may interact with certain dimensions of the suicidal process. However, it is time to innovate. Several suicide prevention tools all have their place in new modes of care and should be tested on a large scale.

Indexed as

BetacoronavirusCoronavirus InfectionsPandemicsPneumonia, ViralAlcoholic IntoxicationArtificial IntelligenceCost of IllnessCOVID-19Crisis InterventionEconomic RecessionFranceHumansInflammationLonelinessModels, NeurologicalPsychotherapyCOVID-19Crise économiqueDéconnexion socialeEconomic crisisPréventionSocial disconnectionSuicidal behaviorSuicidal vulnerabilitySuicideSuicide preventionVulnérabilité suicidaire

Identifiers

PMID32471707
PMCPMC7205618
OpenAlexW3020959800

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.